Collection of biospecimens for biomedical research on various conditions
A Single-Site Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives
This study is collecting samples and medical information from participants to help researchers find new treatments and tests for conditions like age-related macular degeneration, allergies, and Alzheimer's disease.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 20000 (estimated) |
| Ages | 18 Years to 85 Years |
| Sex | All |
| Sponsor | Sanguine Biosciences Industry-sponsored |
| Locations | 1 site (Waltham, Massachusetts) |
| Trial ID | NCT05635266 on ClinicalTrials.gov |
What this trial studies
This observational study aims to collect, preserve, and distribute annotated biospecimens along with associated medical data to support investigator-directed biomedical research. The focus is on discovering and developing new treatments, diagnostics, and preventative methods for conditions such as age-related macular degeneration, allergies, and Alzheimer's disease. Participants will provide samples and medical history to aid in this research initiative.
Who should consider this trial
Good fit: Ideal candidates are individuals aged 18 to 85 with a confirmable diagnosis of specific conditions.
Not a fit: Patients younger than 18 or older than 85, or those with certain medical conditions that increase phlebotomy risks, may not benefit from this study.
Why it matters
Potential benefit: If successful, this initiative could lead to breakthroughs in the understanding and treatment of complex medical conditions.
How similar studies have performed: Other studies utilizing biospecimen repositories have shown success in advancing medical research, indicating a promising approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Persons 18 to 85 years of age at the date of informed consent. * If presenting with a history of a specific condition, the diagnosis is confirmable in the medical record or may be confirmed using other forms of verification including self-reporting. * Understands the procedures and requirements of the study by providing written informed consent (or verbal assent if a legally authorized representative will sign the ICF), including consent for authorization for protected health information disclosure. Exclusion Criteria: * Persons younger than 18 years of age or older than 85 years of age at the date of informed consent. * Receipt of blood products 30 days before the study blood draw. * Receipt of an investigational (unapproved) drug 30 days before the study blood draw. * A confirmable diagnosis of any medical condition that would increase potential phlebotomy risks. * Has donated a unit of blood within the last 2 months at the date of informed consent.
Where this trial is running
Waltham, Massachusetts
- Sanguine Biosciences — Waltham, Massachusetts, United States (Recruiting)
Study contacts
- Principal investigator: Houman Hemmati, MD — Sanguine Biosciences
- Study coordinator: Carolyn Bidwell
- Email: study@sanguinebio.com
- Phone: 855.836.4759
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.